Skip to main content

Taclonex Side Effects

Generic name: betamethasone / calcipotriene topical

Medically reviewed by Drugs.com. Last updated on Jun 20, 2023.

Note: This document contains side effect information about betamethasone / calcipotriene topical. Some dosage forms listed on this page may not apply to the brand name Taclonex.

Applies to betamethasone/calcipotriene topical: topical application cream, topical application foam, topical application ointment, topical application suspension.

Serious side effects of Taclonex

Along with its needed effects, betamethasone/calcipotriene topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking betamethasone / calcipotriene topical:

Less common

Rare

Incidence not known

Other side effects of Taclonex

Some side effects of betamethasone / calcipotriene topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

Rare

Incidence not known

For Healthcare Professionals

Applies to betamethasone / calcipotriene topical: topical cream, topical foam, topical ointment, topical suspension.

Dermatologic

Very common (10% or more): Pruritus (17%)

Common (1% to 10%): Skin exfoliation

Uncommon (0.1% to 1%): Skin infection, folliculitis, skin atrophy, exacerbation of psoriasis, dermatitis, erythema, rash (e.g., exfoliative, papular, pustular), purpura, ecchymosis, skin burning sensation, skin irritation

Rare (less than 0.1%): Furuncle, pustular psoriasis, skin striae, photosensitivity reaction, acne, dry skin[Ref]

Nervous system

Very common (10% or more): Headache (16%)[Ref]

Metabolic

Rare (less than 0.1%): Hypercalcemia, hyperglycemia[Ref]

Endocrine

Very common (10% or more): Adrenal suppression (15%)

Rare (less than 0.1%): Cushing's syndrome[Ref]

Hypersensitivity

Rare (less than 0.1%): Hypersensitivity[Ref]

Respiratory

Very common (10% or more): Nasopharyngitis (11%)

Common (1% to 10%): Upper respiratory tract infection[Ref]

Local

Uncommon (0.1% to 1%): Application site pigmentation changes, application site pain/burning[Ref]

Ocular

Frequency not reported: Vision blurred[Ref]

Frequently asked questions

References

1. Product Information. Taclonex (betamethasone-calcipotriene topical). Leo Pharma Inc. 2022.

2. Product Information. Enstilar (betamethasone-calcipotriene topical). Leo Pharma Inc. 2022.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.